APA (7th ed.) Citation

Jang, H., Lee, H., Ramos, D., Park, I. K., Kang, C. H., Burt, B. M., & Kim, Y. T. (2020). Transcriptome-based molecular subtyping of non–small cell lung cancer may predict response to immune checkpoint inhibitors. The Journal of thoracic and cardiovascular surgery, 159(4), 1598-1610.e3. https://doi.org/10.1016/j.jtcvs.2019.10.123

Chicago Style (17th ed.) Citation

Jang, Hee-Jin, Hyun-Sung Lee, Daniela Ramos, In Kyu Park, Chang Hyun Kang, Bryan M. Burt, and Young Tae Kim. "Transcriptome-based Molecular Subtyping of Non–small Cell Lung Cancer May Predict Response to Immune Checkpoint Inhibitors." The Journal of Thoracic and Cardiovascular Surgery 159, no. 4 (2020): 1598-1610.e3. https://doi.org/10.1016/j.jtcvs.2019.10.123.

MLA (9th ed.) Citation

Jang, Hee-Jin, et al. "Transcriptome-based Molecular Subtyping of Non–small Cell Lung Cancer May Predict Response to Immune Checkpoint Inhibitors." The Journal of Thoracic and Cardiovascular Surgery, vol. 159, no. 4, 2020, pp. 1598-1610.e3, https://doi.org/10.1016/j.jtcvs.2019.10.123.